BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1111 related articles for article (PubMed ID: 17654125)

  • 41. What is new with the beta2-agonists: issues in the management of asthma.
    Kelly HW
    Ann Pharmacother; 2005 May; 39(5):931-8. PubMed ID: 15811904
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combination therapy with inhaled long-acting beta2-agonists and inhaled corticosteroids: a paradigm shift in asthma management.
    Stoloff S; Poinsett-Holmes K; Dorinsky PM
    Pharmacotherapy; 2002 Feb; 22(2):212-26. PubMed ID: 11837559
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Drugs for asthma.
    Treat Guidel Med Lett; 2005 May; 3(33):33-8. PubMed ID: 15821635
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Leukotriene antagonists as first-line or add-on asthma-controller therapy.
    Price D; Musgrave SD; Shepstone L; Hillyer EV; Sims EJ; Gilbert RF; Juniper EF; Ayres JG; Kemp L; Blyth A; Wilson EC; Wolfe S; Freeman D; Mugford HM; Murdoch J; Harvey I
    N Engl J Med; 2011 May; 364(18):1695-707. PubMed ID: 21542741
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Importance of leukotriene antagonists in asthma therapy raised].
    MMW Fortschr Med; 2008 Mar; 150(13):44-5. PubMed ID: 18522358
    [No Abstract]   [Full Text] [Related]  

  • 46. Combination therapy of bronchial asthma.
    Nelson HS
    Allergy Asthma Proc; 2001; 22(4):217-20. PubMed ID: 11552671
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhaled steroid therapy and hospitalization for bronchial asthma: trend in Tokushima University Hospital.
    Yanagawa H; Shiraga M; Nakamura Y; Azuma M; Yoneda K; Ogawa H; Kitamuro C; Maeda K; Miki M; Matsumori Y; Sugita A; Hashimoto S; Hara C; Tani K; Sone S
    J Med Invest; 2003 Feb; 50(1-2):72-7. PubMed ID: 12630571
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Friend or foe: combination therapy with inhaled corticosteroids and long-acting beta2-agonists in chronic obstructive pulmonary disease (COPD)].
    Gillissen A; Gessner C; Hoheisel G; Juergens U
    Pneumologie; 2008 Jul; 62(7):430-7. PubMed ID: 18398787
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recent advances in corticosteroids for the treatment of asthma.
    Bhalay G; Sandham DA
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1149-56. PubMed ID: 12211406
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment options for the management of exercise-induced asthma and bronchoconstriction.
    Millward DT; Tanner LG; Brown MA
    Phys Sportsmed; 2010 Dec; 38(4):74-80. PubMed ID: 21150145
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term effects of asthma medications in children.
    Tamesis GP; Covar RA
    Curr Opin Allergy Clin Immunol; 2008 Apr; 8(2):163-7. PubMed ID: 18317027
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of long-acting beta2 agonists on exacerbation rates of asthma in children.
    Gustafsson PM; Kiri VA
    Pediatr Pulmonol; 2004 Oct; 38(4):362-4; author reply 364-6. PubMed ID: 15334522
    [No Abstract]   [Full Text] [Related]  

  • 53. Achieving therapeutic benefits of inhaled corticosteroids/beta2 agonist in chronic obstructive airway disease.
    Wang ZL
    Chin Med J (Engl); 2007 Jun; 120(12):1097-105. PubMed ID: 17637229
    [No Abstract]   [Full Text] [Related]  

  • 54. Effect of long-acting beta2 agonists on exacerbation rates of asthma in children.
    Bisgaard H
    Pediatr Pulmonol; 2003 Nov; 36(5):391-8. PubMed ID: 14520721
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Safety and efficacy of beta agonists.
    Donohue JF
    Respir Care; 2008 May; 53(5):618-22; discussion 623-4. PubMed ID: 18426615
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.
    Ye X; Gutierrez B; Zarotsky V; Nelson M; Blanchette CM
    Curr Med Res Opin; 2009 Sep; 25(9):2251-8. PubMed ID: 19622006
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combination therapy with a long-acting beta2-agonist and an inhaled corticosteroid as initial maintenance treatment in asthma.
    Lee DK; Currie GP; Lipworth BJ
    Ann Allergy Asthma Immunol; 2005 Mar; 94(3):410-1; author reply 411-2. PubMed ID: 15801257
    [No Abstract]   [Full Text] [Related]  

  • 58. Treatment persistence with leukotriene receptor antagonists and inhaled corticosteroids.
    Dorais M; Blais L; Chabot I; LeLorier J
    J Asthma; 2005 Jun; 42(5):385-93. PubMed ID: 16036414
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhaled corticosteroids vs. leukotriene-receptor antagonists and asthma exacerbations in children.
    Blais L; Kettani FZ; Lemière C; Beauchesne MF; Perreault S; Elftouh N; Ducharme FM
    Respir Med; 2011 Jun; 105(6):846-55. PubMed ID: 21196105
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evidence-based pharmacologic treatment for mild asthma.
    Koh MS; Irving LB
    Int J Clin Pract; 2007 Aug; 61(8):1375-9. PubMed ID: 17590220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 56.